{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:01:30Z","timestamp":1791057690842,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s10552-009-9477-x","type":"journal-article","created":{"date-parts":[[2009,11,30]],"date-time":"2009-11-30T08:33:39Z","timestamp":1259570019000},"page":"463-472","source":"Crossref","is-referenced-by-count":39,"title":["Blood pressure and risk of prostate cancer: cohort Norway (CONOR)"],"prefix":"10.1007","volume":"21","author":[{"given":"Richard M.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Vatten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gunnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l","family":"Romundstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,1]]},"reference":[{"issue":"38","key":"9477_CR1","doi-asserted-by":"crossref","first-page":"6329","DOI":"10.1038\/sj.onc.1207726","volume":"23","author":"DM Parkin","year":"2004","unstructured":"Parkin DM (2004) International variation. Oncogene 23(38):6329\u20136340","journal-title":"Oncogene"},{"issue":"1","key":"9477_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oxfordjournals.epirev.a000792","volume":"23","author":"AW Hsing","year":"2001","unstructured":"Hsing AW, Devesa SS (2001) Trends and patterns of prostate cancer: what do they suggest? Epidemiol Rev 23(1):3\u201313","journal-title":"Epidemiol Rev"},{"key":"9477_CR3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ijc.23520","volume":"123","author":"C Bouchardy","year":"2008","unstructured":"Bouchardy C, Fioretta G, Rapiti E, Verkooijen HM, Rapin CH, Schmidlin F et al (2008) Recent trends in prostate cancer mortality show a continuous decrease in several countries. Int J Cancer 123:421\u2013429","journal-title":"Int J Cancer"},{"key":"9477_CR4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1046\/j.1464-410X.2002.2822.x","volume":"90","author":"M Quinn","year":"2002","unstructured":"Quinn M, Babb P (2002) Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons. BJU International 90:162\u2013173","journal-title":"BJU International"},{"issue":"9","key":"9477_CR5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/jnci\/80.9.683","volume":"80","author":"R Yatani","year":"1988","unstructured":"Yatani R, Shiraishi T, Nakakuki K, Kusano I, Takanari H, Hayashi T et al (1988) Trends in frequency of latent prostate carcinoma in Japan from 1965\u20131979 to 1982\u20131986. J Natl Cancer Inst 80(9):683\u2013687","journal-title":"J Natl Cancer Inst"},{"issue":"6835","key":"9477_CR6","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/35077256","volume":"411","author":"J Peto","year":"2001","unstructured":"Peto J (2001) Cancer epidemiology in the last century and the next decade. Nature 411(6835):390\u2013395","journal-title":"Nature"},{"issue":"1","key":"9477_CR7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/ije\/20.1.76","volume":"20","author":"H Yu","year":"1991","unstructured":"Yu H, Harris RE, Gao YT, Gao R, Wynder EL (1991) Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus the United States. Int J Epidemiol 20(1):76\u201381","journal-title":"Int J Epidemiol"},{"issue":"1","key":"9477_CR8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/ije\/dym219","volume":"37","author":"T Rastogi","year":"2008","unstructured":"Rastogi T, Devesa S, Mangtani P, Mathew A, Cooper N, Kao R et al (2008) Cancer incidence rates among South Asians in four geographic regions: India, Singapore, UK and US. Int J Epidemiol 37(1):147\u2013160","journal-title":"Int J Epidemiol"},{"issue":"6","key":"9477_CR9","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/01.CIR.97.6.596","volume":"97","author":"KS Reddy","year":"1998","unstructured":"Reddy KS, Yusuf S (1998) Emerging epidemic of cardiovascular disease in developing countries. Circulation 97(6):596\u2013601","journal-title":"Circulation"},{"issue":"11\/12","key":"9477_CR10","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1055\/s-2004-814147","volume":"35","author":"E Giovannucci","year":"2003","unstructured":"Giovannucci E (2003) Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res 35(11\/12):694\u2013704","journal-title":"Horm Metab Res"},{"issue":"4","key":"9477_CR11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1467-789X.2002.00081.x","volume":"3","author":"RJ Barnard","year":"2002","unstructured":"Barnard RJ, Aronson WJ, Tymchuk CN, Ngo TH (2002) Prostate cancer: another aspect of the insulin-resistance syndrome? Obes Rev 3(4):303\u2013308","journal-title":"Obes Rev"},{"issue":"9623","key":"9477_CR12","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(08)60655-8","volume":"371","author":"CM Lawes","year":"2008","unstructured":"Lawes CM, Hoorn SV, Rodgers A (2008) Global burden of blood-pressure-related disease, 2001. Lancet 371(9623):1513\u20131518","journal-title":"Lancet"},{"issue":"7915","key":"9477_CR13","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0140-6736(75)91826-7","volume":"305","author":"A Dyer","year":"1975","unstructured":"Dyer A, Berkson D, Stamler J, Lindberg H, Stevens E (1975) High blood pressure: a risk factor for cancer mortality? Lancet 305(7915):1051\u20131056","journal-title":"Lancet"},{"issue":"6","key":"9477_CR14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0002-9343(02)01049-5","volume":"112","author":"E Grossman","year":"2002","unstructured":"Grossman E, Messerli FH, Boyko V, Goldbourt U (2002) Is there an association between hypertension and cancer mortality? Am J Med 112(6):479\u2013486","journal-title":"Am J Med"},{"issue":"3","key":"9477_CR15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/01.HYP.28.3.321","volume":"28","author":"P Hamet","year":"1996","unstructured":"Hamet P (1996) Cancer and hypertension: an unresolved issue. Hypertension 28(3):321\u2013324","journal-title":"Hypertension"},{"issue":"5","key":"9477_CR16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/cncr.22461","volume":"109","author":"JL Beebe-Dimmer","year":"2007","unstructured":"Beebe-Dimmer JL, Dunn RL, Sarma AV, Montie JE, Cooney KA (2007) Features of the metabolic syndrome and prostate cancer in African-American men. Cancer 109(5):875\u2013881","journal-title":"Cancer"},{"key":"9477_CR17","doi-asserted-by":"crossref","unstructured":"Martin R, Vatten L, Gunnell D, Romundstad P, Nilsen T (2009) Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway. Cancer Causes Control. doi: 10.1007\/s10552-009-9319-x","DOI":"10.1007\/s10552-009-9319-x"},{"issue":"3","key":"9477_CR18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1569-9056(08)60505-9","volume":"7","author":"MJ Davis","year":"2008","unstructured":"Davis MJ, Lane JA, Gilbert R, Martin R, Donovan JL, Neal DE et al (2008) Raised blood pressure predicts prostate cancer and elevated PSA in a large unselected population of men participating in the ProtecT study. Eur Urol Suppl 7(3):198","journal-title":"Eur Urol Suppl"},{"issue":"1","key":"9477_CR19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/08037050310025735","volume":"13","author":"J Hammarsten","year":"2004","unstructured":"Hammarsten J, Hogstedt B (2004) Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer. Blood Press 13(1):47\u201355","journal-title":"Blood Press"},{"issue":"7","key":"9477_CR20","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S1047-2797(97)00083-5","volume":"7","author":"GD Friedman","year":"1997","unstructured":"Friedman GD (1997) Blood pressure and heart rate: no evidence for a positive association with prostate cancer. Ann Epidemiol 7(7):486\u2013489","journal-title":"Ann Epidemiol"},{"issue":"6","key":"9477_CR21","first-page":"611","volume":"4","author":"PH Gann","year":"1995","unstructured":"Gann PH, Daviglus ML, Dyer AR, Stamler J (1995) Heart rate and prostate cancer mortality: results of a prospective analysis. Cancer Epidemiol Biomarkers Prev 4(6):611\u2013616","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"9477_CR22","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1158\/1055-9965.EPI-07-0777","volume":"16","author":"EA Platz","year":"2007","unstructured":"Platz EA (2007) Epidemiologic musing on statin drugs in the prevention of advanced prostate cancer. Cancer Epidemiol Biomarkers Prev 16(11):2175\u20132180","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"9477_CR23","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S1047-2797(01)00246-0","volume":"11","author":"AL Fitzpatrick","year":"2001","unstructured":"Fitzpatrick AL, Daling JR, Furberg CD, Kronmal RA, Weissfeld JL (2001) Hypertension, heart rate, use of antihypertensives, and incident prostate cancer. Ann Epidemiol 11(8):534\u2013542","journal-title":"Ann Epidemiol"},{"issue":"4","key":"9477_CR24","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ijc.22366","volume":"120","author":"DR Browning","year":"2007","unstructured":"Browning DR, Martin RM (2007) Statins and risk of cancer: a systematic review and metaanalysis. Int J Cancer 120(4):833\u2013843","journal-title":"Int J Cancer"},{"issue":"24","key":"9477_CR25","doi-asserted-by":"crossref","first-page":"8369","DOI":"10.1073\/pnas.0803080105","volume":"105","author":"D Ornish","year":"2008","unstructured":"Ornish D, Magbanua MJ, Weidner G, Weinberg V, Kemp C, Green C et al (2008) Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci USA 105(24):8369\u20138374","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"9477_CR26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/ije\/dym217","volume":"37","author":"O Naess","year":"2008","unstructured":"Naess O, Sogaard AJ, Arnesen E, Beckstrom AC, Bjertness E, Engeland A et al (2008) Cohort profile: cohort of Norway (CONOR). Int J Epidemiol 37(3):481\u2013485","journal-title":"Int J Epidemiol"},{"issue":"24","key":"9477_CR27","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/jnci\/djm249","volume":"99","author":"R Kvale","year":"2007","unstructured":"Kvale R, Auvinen A, Adami HO, Klint A, Hernes E, Moller B et al (2007) Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst 99(24):1881\u20131887","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"9477_CR28","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/ijc.22788","volume":"121","author":"E Giovannucci","year":"2007","unstructured":"Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC (2007) Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer 121(7):1571\u20131578","journal-title":"Int J Cancer"},{"issue":"1","key":"9477_CR29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/oxfordjournals.aje.a009034","volume":"145","author":"EL Kom","year":"1997","unstructured":"Kom EL, Graubard BI, Midthune D (1997) Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 145(1):72\u201380","journal-title":"Am J Epidemiol"},{"issue":"9","key":"9477_CR30","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1158\/1055-9965.EPI-08-0342","volume":"17","author":"L Zuccolo","year":"2008","unstructured":"Zuccolo L, Harris R, Gunnell D, Oliver S, Lane JA, Davis M et al (2008) Height and prostate cancer risk: a large nested case\u2013control study (ProtecT) and meta-analysis. Cancer Epidemiol Biomarkers Prev 17(9):2325\u20132336","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"17","key":"9477_CR31","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","volume":"348","author":"EE Calle","year":"2003","unstructured":"Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 348(17):1625\u20131638","journal-title":"N Engl J Med"},{"issue":"12","key":"9477_CR32","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1002\/ijc.22184","volume":"119","author":"TI Nilsen","year":"2006","unstructured":"Nilsen TI, Romundstad PR, Vatten LJ (2006) Recreational physical activity and risk of prostate cancer: a prospective population-based study in Norway (the HUNT study). Int J Cancer 119(12):2943\u20132947","journal-title":"Int J Cancer"},{"issue":"1","key":"9477_CR33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jcb.10724","volume":"91","author":"MR Freeman","year":"2004","unstructured":"Freeman MR, Solomon KR (2004) Cholesterol and prostate cancer. J Cell Biochem 91(1):54\u201369","journal-title":"J Cell Biochem"},{"issue":"7440","key":"9477_CR34","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/bmj.328.7440.634","volume":"328","author":"B Williams","year":"2004","unstructured":"Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF et al (2004) British hypertension society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 328(7440):634\u2013640","journal-title":"BMJ"},{"key":"9477_CR35","volume-title":"Essential medical statistics","author":"BR Kirkwood","year":"2003","unstructured":"Kirkwood BR, Sterne JAC (2003) Essential medical statistics, 2nd edn. Blackwell Science, Oxford","edition":"2"},{"issue":"2","key":"9477_CR36","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000474163","volume":"30","author":"WA Sakr","year":"1996","unstructured":"Sakr WA, Grignon DJ, Haas GP, Heilbrun LK, Pontes JE, Crissman JD (1996) Age and racial distribution of prostatic intraepithelial neoplasia. Eur Urol 30(2):138\u2013144","journal-title":"Eur Urol"},{"issue":"5","key":"9477_CR37","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/ijc.2910200506","volume":"20","author":"N Breslow","year":"1977","unstructured":"Breslow N, Chan CW, Dhom G, Drury RA, Franks LM, Gellei B et al (1977) Latent carcinoma of prostate at autopsy in seven areas. The international agency for research on cancer, Lyons, France. Int J Cancer 20(5):680\u2013688","journal-title":"Int J Cancer"},{"issue":"22","key":"9477_CR38","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1001\/jama.291.22.2713","volume":"291","author":"JE Johansson","year":"2004","unstructured":"Johansson JE, Andren O, Andersson SO, Dickman PW, Holmberg L, Magnuson A et al (2004) Natural history of early, localized prostate cancer. JAMA 291(22):2713\u20132719","journal-title":"JAMA"},{"issue":"1","key":"9477_CR39","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0959-8049(95)00501-3","volume":"32","author":"S Harvei","year":"1996","unstructured":"Harvei S, Tretli S, Langmark F (1996) Quality of prostate cancer data in the cancer registry of Norway. Eur J Cancer 32(1):104\u2013110","journal-title":"Eur J Cancer"},{"issue":"17","key":"9477_CR40","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1001\/jama.293.17.2095","volume":"293","author":"PC Albertsen","year":"2005","unstructured":"Albertsen PC, Hanley JA, Fine J (2005) 20-Year outcomes following conservative management of clinically localized prostate cancer. J Am Med Assoc 293(17):2095\u20132101","journal-title":"J Am Med Assoc"},{"issue":"4","key":"9477_CR41","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0306-9877(97)90098-0","volume":"48","author":"MF McCarty","year":"1997","unstructured":"McCarty MF (1997) Up-regulation of IGF binding protein-1 as an anticarcinogenic strategy: relevance to caloric restriction, exercise, and insulin sensitivity. Med Hypotheses 48(4):297\u2013308","journal-title":"Med Hypotheses"},{"issue":"10","key":"9477_CR42","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1002\/ijc.24202","volume":"124","author":"MA Rowlands","year":"2009","unstructured":"Rowlands MA, Gunnell D, Harris R, Vatten LJ, Holly JM, Martin RM (2009) Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int J Cancer 124(10):2416\u20132429","journal-title":"Int J Cancer"},{"issue":"9300","key":"9477_CR43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0140-6736(02)07295-1","volume":"359","author":"R Chen","year":"2002","unstructured":"Chen R, Tunstall-Pedoe H (2002) Cancer risk, hypertension, and antihypertensive medication. Lancet 359(9300):77","journal-title":"Lancet"},{"issue":"9123","key":"9477_CR44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0140-6736(98)03228-0","volume":"352","author":"AF Lever","year":"1998","unstructured":"Lever AF, Hole DJ, Gillis CR, McCallum IR, McInnes GT, MacKinnon PL et al (1998) Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 352(9123):179\u2013184","journal-title":"Lancet"},{"issue":"9281","key":"9477_CR45","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(01)05704-X","volume":"358","author":"LH Lindholm","year":"2001","unstructured":"Lindholm LH, Anderson H, Ekbom T, Hansson L, Lanke J, Dahlof B et al (2001) Relation between drug treatment and cancer in hypertensives in the Swedish trial in old patients with hypertension 2: a 5-year, prospective, randomised, controlled trial. Lancet 358(9281):539\u2013544","journal-title":"Lancet"},{"issue":"6878","key":"9477_CR46","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/bmj.306.6878.609","volume":"306","author":"DJ Hole","year":"1993","unstructured":"Hole DJ, Hawthorne VM, Isles CG, McGhee SM, Robertson JW, Gillis CR et al (1993) Incidence of and mortality from cancer in hypertensive patients. BMJ 306(6878):609\u2013611","journal-title":"BMJ"},{"issue":"5","key":"9477_CR47","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s10552-008-9280-0","volume":"20","author":"C Rodriguez","year":"2009","unstructured":"Rodriguez C, Jacobs E, Deka A, Patel A, Bain E, Thun M et al (2009) Use of blood-pressure-lowering medication and risk of prostate cancer in the cancer prevention study II nutrition cohort. Cancer Causes Control 20(5):671\u2013679","journal-title":"Cancer Causes Control"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-009-9477-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-009-9477-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-009-9477-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T17:06:07Z","timestamp":1559235967000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-009-9477-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,1]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["9477"],"URL":"https:\/\/doi.org\/10.1007\/s10552-009-9477-x","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,1]]}}}